摘要
通过文献检索,查阅近十年来发表的有关大肠癌证型分布及生物学基础研究的文献,总结证型分布特征及生物学基础,结果发现,大肠癌常见中医证型以及所涉及分子生物学基础分别是:大肠癌湿热蕴结证和气血亏虚证患者与正常人的蛋白质表达有差异;VEGF、EGF基因表达差异可作为大肠癌脾气亏虚证客观量化的参考指标之一;大肠癌瘀血内证患者与外周血PTEN、CD的表达存在相关性;大肠癌肝肾阴虚证的分子基础涉及组建炎性细胞因子网络。大肠癌的常见证型的分布以及相关分子生物学的研究,可能有助于更好地理解用中医的证治疗癌症的现代策略。
According to literature review, refer to the literature about the syndrome distribution and biology of colorectal cancer published in recent ten years, summarize syndromes distribution characteristics and biological basis. The results showed that the syndrome distribution and the involved biological basis of colorectal cancer are as follow: there are different between patients with accumulation of damp heat syndrome and deficiency of Qi and blood deficiency and normal people in protein expression; VEGF, EGF gene expression can be used as a reference index of quantitatively evaluating the colorectal cancer patients of temper deficiency; there is a correlation between the PTEN, CD expression of peripheral blood and colorectal cancer patients of blood stasis; molecular basis of colorectal cancer patients of Yin deficiency of liver and kidney relates to the formation of inflammatory cytokine network. Study of the distribution of common type of syndrome of colorectal cancer and mosquito-related molecular contributes to a better understanding of modern strategy of treating cancer using syndrome of traditional Chinese medicine.
引文
[1]Jemal A,Bray F,Center MM,et al.G1obal cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
[2]李德绿,吴春晓,郑莹,等.上海市2003~2007年大肠癌发病率和死亡率分析[J].中国肿瘤,2011,20(6):413-418.
[3]李春华.中国传统医学历代对大肠癌的认识文献记载[J].中外健康文摘,2012,9(1):32-33.
[4]周岱翰.肿瘤治验集要[M].广州:广东高等教育出版社,1997:89-90.
[5]张新,孙华,李亚东,等.孙桂芝治疗大肠癌经验[J].山东中医杂志,1998,17(4):173-175.
[6]张代昭.张代昭治癌经验辑要[M].北京:中国医药科技出社,2001:138.
[7]邵梅,舒琦瑾.大肠癌中医证型构成及分布规律初探[J].中华中医药学刊,2012,30(2):436-438.
[8]Chen Z,Wang P.Clinical distribution and molecular basis of Traditional Chinese Medicine ZHENG in cancer[J].Evid Based Complement Alternat Med,2012,2012:783923.
[9]屠德敬,赵海燕,夏溪,等.287例大肠癌中医证候研究[J].中华中医药学刊,2010,28(5):1019-1020.
[10]王晓戎,袁孝兵,储慧琴,等.因子分析和聚类分析联合应用在大肠癌证候分布中的研究[J].时珍国医国药,2012,23(5):1194-1195.
[11]Dai HY,Wang P,Feng LY,et al.The molecular mechanisms of traditional Chinese medicine ZHENG syndromes onpancreatic tumor growth[J].Integr Cancer Ther,2010,9(3):291-297.
[12]Ouyang HQ,Liu LM,Chen Z,et al.Effects of Qingyi Huaji decoction on serum levels ofinterleukin-6,interleukin-8 and tumor necrosis factor-αinnude mice bearing pancreatic tumors[J].Zhong Xi Yi Jie He Xue Bao,2010,8(7):655-661.
[13]Yin JH,Shi WD,Zhu XY,et al.Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenogr aft by targeting to decrease expression of Cyr61 and VEGF[J].Integra Cancer Ther,2012,11(1):37-47.
[14]周小军,周怀力,苟新敏,等.大肠癌湿热蕴结证患者蛋白质差异性表达的研究发现[J].中华肿瘤防治杂志,2010,17(22):1831-1834.
[15]崔同建,孔祥训,蒋云林,等.大肠癌脾虚证与外周血VEGF、EGF基因表达水平的相关性研究[J].福建中医药,2011,42(3):3-4.
[16]Zhang CF.Exploring of blood viscosity in cancer patients[J].Chin J Model Med,2004,14(7):73-75.
[17]张乐,王彬彬,舒琦瑾,等.大肠癌临床分期及中医证型与血浆D-二聚体的相关性研究[J].浙江中医杂志,2010,45(2):96-97.
[18]崔同建,陈香莲,蒋云林,等.复发转移大肠癌血瘀证与外周血PTEN、CD基因表达相关性分析[J].福建中医药大学学报,2011,21(4):1-3.
[19]周小军,周福生,苟新敏,等.大肠癌气血亏虚证患者蛋白质差异性表达的研究[J].中国中西医结合急救杂志,2010,17(5):274-277.
[20]Shen WX,Sun Y,Zhang SR.Study on relation between IL-1a,IL-1b,IL-1Ra gene m RNA expression and Yindeficiency syndrome in lung cancer[J].Bull Med Res,2000,29(8):5-7.
[21]Zheng H,Shen WX,Liu XY,et al.An experimental studyof the gene expression profile of cytokines in Yin deficiency syndrome of different diseases[J].J Basic Clin Oncol,2006,19(6):448-450.
[22]Liu XY,Shen WX,Liu YM,et al.Inflammatory cytokinesprofile in lung cancer with Yin-deficiency syndrome[J].Yi Xue Yan Jiu Za Zhi,2006,35(3):75-76.
[23]Shen WX,Sun Y,Zhang SR.Correlation between IL-8,Il-10 and Yin-deficiency syndrome[J].Bull Med Res,2003,32(5):62-64.
[24]崔同建,陈香莲,蒋云林,等.晚期大肠癌的病性证素与外周血p53、nm23的相关性研究[J].现代消化及介入诊疗,2011,16(4):235-238.
